Lv12
4 积分 2025-05-12 加入
Impact of sarcopenia, BMI, and inflammatory biomarkers on survival in advanced hepatocellular carcinoma treated with anti-PD-1 antibody
1小时前
已完结
The predictive value of a preoperative systemic immune-inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma
1小时前
已完结
Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations
1小时前
已完结
Preliminary results from the multicenter, randomized phase Ⅲ trial (SCIENCE): Comparing chemotherapy plus sintilimab and chemoradiotherapy plus sintilimab versus chemoradiotherapy for neoadjuvant treatment in resectable locally advanced esophageal squamous cell carcinoma
1小时前
已完结
Long-term efficacy of neoadjuvant chemoradiotherapy plus surgery for the treatment of locally advanced esophageal squamous cell carcinoma: the NEOCRTEC5010 randomized clinical trial. JAMA Surg
1小时前
已完结
Preexisting hypertension and cancer therapy:evidence, pathophysiology, and managementrecommendation
14小时前
已完结
The enhanced pathological response from additional immunotherapy improved recurrence-free survival for esophageal squamous cell carcinoma: a multi-center cohort study
7天前
已完结
基于术前CT影像组学生境模型对I~IIIA期可切除非小细胞肺癌预后的预测价值
2个月前
已关闭
Neoadjuvant Chemoradiotherapy vs Chemoimmunotherapy for Esophageal Squamous Cell Carcinoma
2个月前
已完结
皖公网安备34019202002308
